MedTrace Logo

Differences in Treatment Characteristics and Patient and Therapist Satisfaction Between Robot Assisted Therapy and Conventional Occupational Therapy Among Individuals Post Stroke

NCT07425158 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-02-20

No results posted yet for this study

Summary

The purpose of this study is to compare the differences in treatment characteristics and patient and therapist satisfaction, between Robot Assisted Therapy (RAT) and Conventional Occupational Therapy (COT) single session in individuals post stroke.

Conditions

  • CVA (Cerebrovascular Accident)
  • Stroke

Interventions

OTHER

Robot Assisted Therapy (RAT)

Robot Assisted Therapy (RAT): 30-min treatment session of active- assisted movements of shoulder and elbow, using a robotic arm and a computer screen, provides different exercises according to the motor ability of the patient. The robot provides proximal upper limb training in a three-dimensional (3D) environment. The occupational therapist will be planning the treatment by determining the range of motion, the amount of help and support and the level of difficulty of the game. Conventional occupational therapy (COT): 30-min treatment session of active- assisted movements of the shoulder and elbow, using conventional facilities and devices. Treatment includes passive range of motion exercises and active- assistive exercises. The level of support and help will be determined by the occupational therapist.

Sponsors & Collaborators

  • Tel Aviv University

    collaborator OTHER

  • linor kennet

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2022-08-01
Completion
2022-08-01

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07425158 on ClinicalTrials.gov